Management of pituitary tumors in pregnancy

Nature Reviews Endocrinology

Volumn 7, Issue 5, 2011, Pages 301-310

  Bronstein, Marcello D ^a   Paraiba, Diane B ^a   Jallad, Raquel S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; CYPROHEPTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; KETOCONAZOLE; METYRAPONE; MITOTANE; OCTREOTIDE; PEGVISOMANT; PLACENTA LACTOGEN; QUINAGOLIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADRENAL GLAND; CANCER RADIOTHERAPY; CANCER SURGERY; CONCEPTION; CONGENITAL MALFORMATION; CUSHING DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERTILITY; FOLLOW UP; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MORBIDITY; PATIENT SAFETY; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; SPONTANEOUS ABORTION; THYROTROPIN SECRETING ADENOMA; TRANSSPHENOIDAL SURGERY; TUMOR GROWTH;

DOPAMINE AGONISTS; FEMALE; HUMANS; KETOCONAZOLE; METYRAPONE; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 79955086358     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.38     Document Type: Review

References (108)

1. th edn Vol. 1 Ch. 18 (eds DeGroot, L. J. & Jameson, J. L.) 333-357 (Elsevier, Philadelphia, 2010).
2. Klibanski, A. Clinical practice. Prolactinomas. N. Engl. J. Med. 362, 1219-1226 (2010).
3. Sharma, J. B. et al. Pregnancy outcome in pituitary tumors. Arch. Gynecol. Obstet. 280, 401-404 (2009).
4. Bronstein, M. D. Prolactinomas and pregnancy. Pituitary 8, 31-38 (2005). (Pubitemid 44680083)
5. th edn Ch. 8 (eds Kronenberg, H. M., Melmed, S., Polonsky, K. S. & Larsen, P. R.), 255-261 (Elsevier, 2007).
6. Okafor, U. V., Onwuekwe, I. O. & Ezegwui, H. U. Management of pituitary adenoma with mass effect in pregnancy: a case report. Cases J. 2, 6350 (2009).
7. Karaca, Z., Tanriverdi, F., Unluhizarci, K. & Kelestimur, F. Pregnancy and pituitary disorders. Eur. J. Endocrinol. 162, 453-475 (2010).
8. Molitch, M. E. Pituitary disorders during pregnancy. Endocrinol. Metab. Clin. North Am. 35, 99-116 (2006). (Pubitemid 41668868)
9. st edn Vol. 5 Ch. 8 (eds Martins, M. A. et al.) 96-107 (Manole, 2009).
10. Casanueva, F. F. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. (Oxf.) 65, 265-273 (2006). (Pubitemid 44079693)
11. Gillam, M. P., Molitch, M. E., Lombardi, G. & Colao, A. Advances in the treatment of prolactinomas. Endocr. Rev. 27, 485-534 (2006). (Pubitemid 44213229)
12. Colao, A. Pituitary tumours: the prolactinoma. Best Pract. Res. Clin. Endocrinol. Metab. 23, 575-596 (2009).
13. Kars, M., Dekkers, O. M., Pereira, A. M. & Romijn, J. A. Update in prolactinomas. Neth. J. Med. 68, 104-112 (2010).
14. Gemzell, C. & Wang, C. F. Outcome of pregnancy in women with pituitary adenoma. Fertil. Steril. 31, 363-372 (1979). (Pubitemid 9135543)
15. Molitch, M. E. Pregnancy and the hyperprolactinemic woman. N. Engl. J. Med. 312, 1364-1370 (1985). (Pubitemid 15118299)
16. nd edn Ch. 4 (ed. Bronstein, M. D.) 91-108 (Kluwer Academic Publishers, 2001).
17. Molitch, M. E. Prolactinomas and pregnancy. Clin. Endocrinol. (Oxf.) 73, 147-148 (2010).
18. Lebbe, M., Hubinont, C., Bernard, P. & Maiter, D. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin. Endocrinol. (Oxf.) 73, 236-242 (2010).
19. Holmgren, U., Bergstrand, G., Hagenfeldt, K. & Werner, S. Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and on tumour growth. Acta Endocrinol. 111, 452-459 (1986). (Pubitemid 16086309)
20. Robert, E., Musatti, L, Piscitelli, G. & Ferrari, C. I. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod. Toxicol. 10, 333-337 (1996). (Pubitemid 26310263)
21. Krupp, P. & Monka, C. Bromocriptine in pregnancy: safety aspects. Klin. Wochenschr. 65, 823-827 (1987). (Pubitemid 17123339)
22. Ricci, E. et al. Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod. Toxicol. 16, 791-793 (2002). (Pubitemid 35278500)
23. Colao, A. et al. Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clin. Endocrinol. (Oxf.) 68, 66-71 (2008). (Pubitemid 350243483)
24. Ono, M. et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J. Clin. Endocrinol. Metab. 95, 2672-2679 (2010).
25. Webster, J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf. 14, 228-238 (1996). (Pubitemid 26128812)
26. Mancini, T., Casanueva, F. F. & Giustina, A. Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am. 37, 67-99 (2008). (Pubitemid 351146629)
27. Rasmussen, C., Bergh, I, Nillius, S. J. & Wide, L. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy. Fertil. Steril. 44, 31-34 (1985). (Pubitemid 15000544)
28. Bergh, T., Nillius, S. J. & Wide, L. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. Br. Med. J. 1, 875-880 (1978). (Pubitemid 8318876)
29. Crosignani, P.G. et al. Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 44, 175-180 (1992).
30. Badawy, S. Z., Marziale, J. C., Rosenbaum, A. E., Chang, J. K. & Joy, S. E. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas - the value of radiologic studies. Early Pregnancy 3, 306-311 (1997).
31. Yamada, M. et al. Spontaneous pregnancy after a pregnancy induced by treatment in hyperprolactinemic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 35, 125-129 (1990). (Pubitemid 20184052)
32. Christin-Mattre, S., Delemer, B., Touraine, P. & Young, J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. Ann. Endocrinol. (Paris) 68, 106-112 (2007). (Pubitemid 47241115)
33. Peillon, F. et al. Prolactin secretion and synthesis in short- and long-term organ culture of pituitary tumours from acromegalic patients. Acta Endocrinol. 87, 701-715 (1978). (Pubitemid 8303627)
34. Freeman, R. et al. Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus. Fertil. Steril. 58, 427-429 (1992).
35. Freeman, M. E., Kanyicska, B., Lerant, A. & Nagy, G. Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80, 1523-1631 (2000).
36. rd, Francke, U. & Seeburg, P. H. The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter. Hum. Genet. 57, 138-141 (1981). (Pubitemid 11156805)
37. MacLeod, J. N., Lee, A. K., Liebhaber, S. A. & Cooke, N. E. Developmental control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster. J. Biol. Chem. 267, 14219-14226 (1992).
38. Chen, E. Y. et al. The human growth hormone locus nucleotidic sequence, biology, and evolution. Genomics 4, 479-497 (1989).
39. Swenne, I., Hill, D. J., Strain, A. J. & Milner, R. D. Effects of human placental lactogen and growth hormone on the production of insulin and somatomedin C/insulin-like growth factor I by human fetal pancreas in tissue culture. J. Endocrinol. 113, 297-303 (1987). (Pubitemid 17071613)
40. Frankenne, F. et al. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J. Clin. Endocrinol. Metab. 66, 1171-1180 (1988).
41. Eriksson, L., Frankenne, F., Edèn, S., Hennen, G. & Von Schoultz, B. Growth hormone 24-h serum profiles during pregnancy - lack of pulsatility for the secretion of the placental variant. Br. J. Obstet. Gynaecol. 96, 949 (1989).
42. Eriksson, L., Edén, S., Fröhlander, N., Bengtsson, B. A. & von Schoultz, B. Continuous 24-hour secretion of growth hormone during late pregnancy. A regulator of maternal metabolic adjustment? Acta Obstet. Gynecol. Scand. 67, 543-547 (1988). (Pubitemid 19092031)
43. Mclntyre, H. D. et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrinol. Metab. 85, 1143-1150 (2000).
44. Caufriez, A. et al. Placental growth hormone as a potential regulator of maternal IGF-1 during human pregnancy. Am. J. Physiol. 258 (Pt. 1), E1014-E1019 (1990). (Pubitemid 20210385)
45. Caufriez, A., Frankenne, F., Hennen, G. & Copinschi, G. Regulation of maternal IGP-1 by placental GH in normal and abnormal human pregnancies. Am. J. Physiol. 265 (Pt. 1), E572-E577 (1993).
46. Alsat, E., Guibourdenche, J., Luton, D., Frankenne, P. & Evain-Brion, D. Human placental growth hormone. Am. J. Obstet. Gynecol. 177, 1526 (1997).
47. Daughaday, W. H.,Trivedi, B., Winn, H. N. & Yan, H. Hypersomatotropism in pregnant women, as measured by a human liver radioreceptor assay. J. Clin. Endocrinol. Metab. 70, 215-221 (1990).
48. Mirlesse, V. et al. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr. Res. 34, 439-442 (1993). (Pubitemid 23297171)
49. Kaltsas, G. A. et al. Menstrual irregularity in women with acromegaly. J. Clin. Endocrinol. Metab. 84, 2731-2735 (1999). (Pubitemid 30642002)
50. Katznelson, L. et al. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin. Endocrinol. (Oxf.) 54, 183-188 (2001). (Pubitemid 32193519)
51. Kaltsas, G. A. et al. Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin. Endocrinol. (Oxf.). 67, 917-922 (2007). (Pubitemid 350135137)
52. Grynberg, M., Salenave, S., Young, J. & Chanson, P. Female gonadal function before and after treatment of acromegaly. J. Clin. Endocrinol. Metab. 95, 4518-4525 (2010).
53. Jamnongjit, M., Gill, A. & Hammes, S. R. Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation. Proc. Natl Acad. Sci. USA 102, 16257-16261 (2005).
54. Caron, P. et al. Acromegaly and Pregnancy: A retrospective multicenter study of 59 pregnancies in 46 women. J. Clin. Endocrinol. Metab. 95, 4680-4687 (2010).
55. Beckers, A., Stevenaert, A., Foidart, J. M., Hennen, G. & Frankenne, F. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J. Clin. Endocrinol. Metab. 71, 725-731 (1990).
56. Serri, O. & Lanoie, G. Successful pregnancy in a woman with acromegaly treated with octreotide long-acting release. Endocrinologist 13, 17-19 (2003). (Pubitemid 36105619)
57. Lau, S. L., McGrath, S., Evain-Brion, D. & Smith, R. Clinical and biochemical improvement in acromegaly during pregnancy. J. Endocrinol. Invest. 31, 255-261 (2008). (Pubitemid 351638406)
58. Bétéa, D., Valdes Socin, H., Hansen, I., Stevenaert, A. & Beckers, A. Acromegaly and pregnancy [French]. Ann. Endocrinol. (Paris) 63, 457-463 (2002).
59. Lunardi, P., Rizzo, A., Missori, P. & Fraioli, B. Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transphenoidal approach. Int. J. Gynaecol. Obstet. 34, 71-74 (1991). (Pubitemid 20378392)
60. Atmaca, A., Dagdelen, S. & Erbas, T. Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp. Clin. Endocrinol. Diabetes 114, 135-139 (2006).
61. Cozzi, R., Attanasio, R. & Barausse, M. Pregnancy in acromegaly: a one-center experience. Eur. J. Endocrinol. 155(2), 279-284 (2006). (Pubitemid 44269444)
62. Leung, K. C., Johannsson, G., Leong, G. M. & Ho, K. K. Estrogen regulation of growth hormone action. Endocr. Rev. 25, 693-721 (2004). (Pubitemid 39366048)
63. Obuobie, K. et al. McCune-Albright syndrome: growth hormone dynamics in pregnancy. J. Clin. Endocrinol. Metab. 86, 2456-2458 (2001). (Pubitemid 32545691)
64. Herman-Bonert, V., Seliverstov, M. & Melmed, S. Pregnancy in acromegaly: Successful therapeutic outcome. J. Clin. Endocrinol. Metab. 83, 727-731 (1998). (Pubitemid 28496436)
65. Abelove, W. A., Rupp, J. J. & Paschkis, K. E. Acromegaly and pregnancy. J. Clin. Endocrinol. Metab. 14, 32-44 (1954).
66. Qureshi, A. et al. IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. J. Assist. Reprod. Genet. 23, 439-442 (2006). (Pubitemid 46020547)
67. Guven, S. et al. A case of acromegaly in pregnancy: concomitant transphenoidal adenomectomy and cesarean section. J. Matern. Fetal Neonatal Med. 19, 69-71 (2006).
68. th edn Vol. 2 Ch. 29 (ed. Miller, R. D.) 509-528 (Lippincott Williams & Wilkins, 2002).
69. Caron, P., Gerbeau, C. & Pradayrol, L. Maternal-fetal transfer of octreotide. N. Engl. J. Med. 333, 601-602 (1995).
70. Caron, P., Gerbeau, C., Pradayrol, L., Cimonetta, C. & Bayard, F. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J. Clin. Endocrinol. Metab. 81, 1164-1168 (1996). (Pubitemid 26083988)
71. Caron, P. et al. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J. Clin. Endocrinol. Metab. 82, 3771-3776 (1997). (Pubitemid 27509370)
72. Maffei, P. et al. Effects of octreotide exposure during pregnancy in acromegaly. Clin. Endocrinol. (Oxf.) 72, 668-677 (2010).
73. Tsalikian, E., Foley, I. P. Jr & Becker, D. J. Characterization of somatostatin specific binding in plasma membranes of human placenta. Pediatr. Res. 18, 953-957 (1984). (Pubitemid 14024256)
74. Fassnacht, M., Capelier, B., Arlt, W., Steck, T. & Allolio, B. Octreotide LAR treatment throughout pregnancy in acromegalic woman. Clin. Endocrinol. (Oxf.) 55, 411-415 (2001). (Pubitemid 32823052)
75. Bigazzi, M. et al. A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal and amniotic compartments. J. Clin. Endocrinol. Metab. 48, 9-12 (1979). (Pubitemid 9101602)
76. Aono, T., Shioji, T., Kohno, M., Ueda, G. & Kurachi, K. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea. Fertil. Steril. 27, 341-344 (1976).
77. Espersen, T. & Ditzel, J. Pregnancy and delivery under bromocriptine therapy. Lancet 2, 985-986 (1977).
78. Luboshitzky, R., Dickstein, G. & Barzilai, D. Bromocriptine induced pregnancy in an acromegalic patient. JAMA 244, 584-586 (1980). (Pubitemid 10087189)
79. Hisano, M. et al. An acromegalic woman first diagnosed in pregnancy. Arch. Gynecol. Obstet. 274,, 171-173 (2005).
80. Brian, S. R., Bidlingmaier, M., Wajnrajch, M. P., Weinzimer, S. A. & Inzucchi, S. E. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J. Clin. Endocrinol. Metab. 92, 3374-3377 (2007). (Pubitemid 47435307)
81. Vilar, L., Freitas, Mda. C., Lima, L. H., Lyra, R. & Kater, C. E. Cushing's syndrome in pregnancy: an overview. Arq. Bras. Endocrinol. Metabol. 51, 1293-1302 (2007).
82. Hunt, A. B. & McConahey, W. M. Pregnancy associated with disease of the adrenal glands. Am. J. Obstet. Gynecol. 66, 970-987 (1953).
83. Buescher, M. A., McClamrock, H. D. & Adashi, E. Y. Cushing syndrome in pregnancy. Obstet. Gynecol. 79, 130-137 (1992).
84. Pickard, J., Jochen, A. L., Sadur, C. N. & Hofeldt, F. D. Cushing's syndrome in pregnancy. Obstet. Gynecol. Surv. 45, 87-93 (1990). (Pubitemid 20112364)
85. Klibanski, A., Stephen, A. E., Greene, M. F., Blake, M. A. & Wu, C. L. Case records of the Massachusetts General Hospital. Case 36-2006. A 35-year-old pregnant woman with new hypertension. N. Engl. J. Med. 355, 2237-2245 (2006). (Pubitemid 44791166)
86. Cohade, C. et al. Ectopic Cushing's syndrome due to a pheochromocytoma: a new case in the postpartum and review of literature. Gynecol. Endocrinol. 25, 624-627 (2009).
87. Chui, M. H. et al. Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome. Endocr. Pathol. 20, 256-261 (2009).
88. Aran, D. C., Schnall, A. M. & Sheeler, L. R. Cushing's syndrome and pregnancy. Am. J. Obstet. Gynecol. 162, 244-252 (1990). (Pubitemid 20055460)
89. Lindsay, J. R., Jonklaas, J., Oldfield, E. H. & Nieman, L. K. Cushing's syndrome during pregnancy: personal experience and review of the literature. J. Clin. Endocrinol. Metab. 90, 3077-3083 (2005). (Pubitemid 40686367)
90. Lindsay, J. R. & Nieman, L. K. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr. Rev. 26, 775-799 (2005). (Pubitemid 41428538)
91. Bronstein, M. D., Salgado, L. R. & de Castro Musolino, N. R. Medical management of pituitary adenomas: the special case of management of the pregnant woman. Pituitary 5, 99-107 (2002). (Pubitemid 36336015)
92. Cabezón, C., Bruno, O. D., Cohen, M., García, S. & Gutman, R. A. Twin pregnancy in a patient with Cushing's disease. Fertil. Steril. 72, 371-372 (1999). (Pubitemid 29364643)
93. Ross, R. J. et al. Diagnosis and selective cure of Cushing's disease during pregnancy by transsphenoidal surgery. Eur. J. Endocrinol. 132, 722-726 (1995).
94. Mellor, A., Harvey, R. D., Pobereskin, L. H. & Sneyd, J. R. Cushing's disease treated by trans-sphenoidal selective adenomectomy in mid-pregnancy. Br. J. Anaesth. 80, 850-852 (1998). (Pubitemid 28282567)
95. Lo, C. Y., Lo, C. M. & Lam, K. Y. Cushing's syndrome secondary to adrenal adenoma during pregnancy. Surg. Endosc. 16, 219-220 (2002).
96. Bertagna, X., Guignat, L., Groussin, L. & Bertherat, J. Cushing's disease. BestPract. Res. Clin. Endocrinol. Metab. 23, 607-623 (2009).
97. Connell, J. M. et al. Pregnancy complicated by Cushing syndrome: potential hazard of metyrapone therapy (case report). Br. J. Obstet. Gynaecol. 92, 1192-1195 (1985). (Pubitemid 16258024)
98. Hána, V., Dokoupilová, M., Marek, J. & Plavka, R. Recurrent ACTH independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. Clin. Endocrinol. (Oxf). 54, 277-281 (2001). (Pubitemid 32193532)
99. Wallace, C., Toth, E. L., Lewanczuk, R. Z. & Siminoski, K. Pregnancy-induced Cushing's syndrome in multiple pregnancies. J. Clin. Endocrinol. Metab. 81, 15-21 (1996).
100. Amado, J. A. et al. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad. Med. J. 66, 221-223 (1990). (Pubitemid 20083082)
101. Berwaerts, J., Verfielst, J., Mahler, C. & Abs, R. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecol. Endocrinol. 13, 175-182 (1999). (Pubitemid 29313216)
102. nd edn Ch. 4 (ed Bronstein, M. D) 173-194 (Kluwer Academic Publishers, 2001).
103. Masding, M. G., Lees, P. D., Gawne-Cain, M. L. & Sandeman, D. D. Visual field compression by a non-secreting pituitary tumour during pregnancy. J. R. Soc. Med. 96, 27-28 (2003). (Pubitemid 36106275)
104. Caron, P., Gerbeau, C., Pradayrol, L., Simonetta, C. & Bayard, F. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J. Clin. Endocrinol. Metab. 81, 1164-1168 (1996). (Pubitemid 26083988)
105. Blackhurst, G. et al. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin. Endocrinol. (Oxf.) 57, 401-404 (2002). (Pubitemid 35013821)
106. Chaiamnuay, S., Moster, M., Katz, M. R. & Kim, Y. N. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 6, 109-113 (2003). (Pubitemid 37536863)
107. Gonzalez, J. G. et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am. J. Med. 85, 217-220 (1988).
108. Glezer, A. et al. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J. Clin. Endocrinol. Metab. 91, 1048-1055 (2006). (Pubitemid 43357779)